Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Drug therapy and pharmacogenomics--hopes and facts].

Wiener medizinische Wochenschrift (1946) - 1 Feb 2005

Müller-Zellenberg Ulrike, Müller Markus

Abstract excerpt

Recent achievements in molecular genetics, in particular the characterization of a large number of non-synonymous single-nucleotide polymorphisms (ns-SNPs) have led to a substantial accumulation of knowledge about the mechanisms of interindividual variability in drug response. The concept of elucidating drug reactions by genetic analysis is termed "pharmacogenomics". Pharmacogenomics is set to provide a relevant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pharmacogenetics
Share to Dose-Response Relationship, Drug
Share to Drug-Related Side Effects and Adverse Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy

Share to Incidence

Share to Introns

Share to Pharmaceutical Preparations

Source

Identifiers

PMID: 15791775
DOI: 10.1007/s10354-004-0145-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Drug therapy and pharmacogenomics--hopes and facts].PMID 15791775Read ↗

Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice.Semantic proximity Read ↗

Advances in pharmacogenetics and pharmacogenomics.Semantic proximity Read ↗

Pharmacogenomics: questions and concerns.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: development, science, and translation.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?Semantic proximity Read ↗

Role of pharmacogenomics in the drug development.Semantic proximity Read ↗

Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.Semantic proximity Read ↗

The emerging era of pharmacogenomics: current successes, future potential, and challenges.Semantic proximity Read ↗

Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug ReactionsSemantic proximity Read ↗

Pharmacogenetics and adverse drug reactions.Semantic proximity Read ↗

[Clinical relevance of drug metabolism polymorphisms].Semantic proximity Read ↗

Pharmacogenomics: Challenges and OpportunitiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.